The Regulation of TRH and Serotonin Receptors: Chronic TRH and Analog Administration in the Rat

References

• Parry O., Roberts M. H.T. The responses of motoneurons to 5-hydroxytryptamine. Neuropharmacology 1980; 19: 515
   PubMed Web of Science ®Google Scholar
• Clarke K. A., Stirk G. Motoneurone excitability after administration of a thyrotropin releasing hormone analogue. Br. J. Pharmac. 1983; 80: 561
   PubMed Web of Science ®Google Scholar
• Gilbert R. F.T., Emson P. C., Hunt S. P., Bennett G. W., Marsden C. A., Sandberg B. E.B., Steinbusch H. W. The effects of monoamine neurotoxins on peptides in the rat spinal cord. Neuroscience 1982; 7: 69
   PubMed Web of Science ®Google Scholar
• Sharif N. A., Burt D. R., Towle A. C., Mueller R. A., Breese G. R. Codepletion of serotonin and TRH induces apparent supersensitivity of spinal TRH receptors. Eur. J. Pharmacol. 1983; 95: 301
   PubMed Web of Science ®Google Scholar
• Hokfelt T., Fuxe K., Johansson O., Jeffcoate S., White N. Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry. Eur. J. Pharmacol. 1975; 34: 389
   PubMed Web of Science ®Google Scholar
• Johansson D., Hokfelt T., Pernow B., Jeffcoate S. L., White N., Steinbusch H. W.M., Verhofstad A. A.J., Emson P. C., Spindel E. Immunohistochemical support for three putative transmitters in one neuron: co-existence of 5-HT, substance P and TRH-like immunoreactivity in medullary neurons projecting to the spinal cord. Neuroscience 1981; 6: 1857
   PubMed Web of Science ®Google Scholar
• Lighton C., Marsden C. A., Bennett G. W. The effects of 5,7-dihydroxytryptamine and pchlorophenylalanine on thyrotropin-releasing hormone in regions of rat brain and spinal cord. Neuropharmacology 1984; 23: 55
   PubMed Web of Science ®Google Scholar
• Jacobs B. An animal model for studying central serotonergic synapses. Life Sci. 1976; 19: 777
   PubMed Web of Science ®Google Scholar
• Boschi G., Launay N., Rips R. Induction of wet-dog shakes by intracerebral “acid” TRH in rats. Neurosci. Lett. 1980; 16: 209
   PubMed Web of Science ®Google Scholar
• Barbeau H., Bedard P. Similar motor effects of 5-HT and TRH in rats following chronic spinal transection and 5,7-dihydroxytryptamine injection. Neuropharmacology 1981; 20: 477
   PubMed Web of Science ®Google Scholar
• Green A. R., Grahame-Smith D. G. TRH potentiates behavioral changes following increased brain 5-hydroxytryptamine accumulation in rats. Nature 1974; 251: 524
   PubMed Web of Science ®Google Scholar
• Rastogi R. B., Singhal R. L., Lapierre Y. D. Thyrotropin releasing hormone potentiates the effects of imipramine on brain serotonergic systems. Brain Res. Bull. 1981; 7: 449
   PubMed Web of Science ®Google Scholar
• Burt D. R., Snyder S. H. Thyrotropin releasing hormone (TRH): apparent receptor binding in rat brain membranes. Brain Research 1975; 93: 309
   PubMed Web of Science ®Google Scholar
• Taylor R. L., Burt R. Properties of [3H] (3Me-His2) TRH binding to apparent TRH receptors in sheep central nervous system. Brain Research 1981; 218: 207
   PubMed Web of Science ®Google Scholar
• Simasko S. M., Horita A. Characterization and distribution of 3H-(3-Me-His2) thyrotropin releasing hormone receptors in rat brain. Life Sci. 1982; 30: 1793
   PubMed Web of Science ®Google Scholar
• Sharif N. A., Burt D. R. Rat brain TRH receptors: kinetics, pharmacology, distribution and ionic effects. Regul. Peptides 1983; 7: 399
   PubMedGoogle Scholar
• Trulson M. E., Jacobs B. L. Behavioral evidence for denervation supersensitivity after destruction of central serotonergic nerve terminals. Ann. N.Y. Acad. Sci. 1978; 305: 497
   PubMedGoogle Scholar
• Nelson D. L., Herbet A., Bourgoin S., Glowinski J., Hamon M. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Mol. Pharmacol. 1978; 14: 983
   PubMed Web of Science ®Google Scholar
• Mueller R. A., Towle A. C., Breese G. R. Supersensitivity to the respiratory stimulatory effect of TRH in 5,7-dihydroxytryptamine-treated rats. Brain Research 1984; 298: 370
   PubMed Web of Science ®Google Scholar
• Griffiths E. C., Widdowson P. S. Involvement of other neurotransmitters in TRH-induced wet-dog shaking. Br. J. Pharmacol. 1985; 86(Suppl)458P
   Google Scholar
• Lin M. T., Chan H. K., Chen C. F., Teh G. W. Involvement of both opiate and catecholaminergic receptors in the behavioral excitation provoked by thyrotropin-releasing hormone: comparisons with amphetamine. Neuropharmacology 1983; 22: 463
   PubMed Web of Science ®Google Scholar
• Pirola C. J., Balda M. S., Finkielman S., Nahmod V. E. Thyrotropin-releasing hormone increases the number of muscarinic receptors in the lateral septal area of the rat brain. Brain Research 1983; 273: 387
   PubMed Web of Science ®Google Scholar
• Oki K., Kinoshita Y., Nomura Y., Segawa T. Influence of thyrotropin-releasing hormone on general behavior and striatal [3H] spiperone binding in developing rats. J. Pharm. Dyn. 1983; 6: 607
   PubMedGoogle Scholar
• Tatsuoka Y., Kato Y., Imura H. Inhibition by DN-1417 (TRH derivative) of [3H] GABA binding in the rat brain. Neurosci. Lett. 1983; 42: 149
   PubMed Web of Science ®Google Scholar
• Yamada K., Matsuki J., Ushijima I., Inone T., Furukawa T. Behavioral studies of shaking behavior induced by thyrotropin-releasing hormone and morphine withdrawal in rats. Arch. Int. Pharmacodyn-Ther. 1983; 262: 24
   PubMedGoogle Scholar
• Metcalf G. Regulatory peptides as a source of new drugs - the clinical prospects for analogues of TRH which are resistant to metabolic degradation. Brain Res. Rev. 1982; 4: 389
   Google Scholar
• Flohe L., Bauer K., Friderichs E., Gunzler W. A., Hennies H. H., Herrling S., Lagler F., Otting F., Schwertner E. Biological effects of degradation - stabilized TRH analogues. Thyrotropin-Releasing Hormone, E. C. Griffiths, G. W. Bennett. Raven Press, New York 1983; 327
   Google Scholar
• Wei E., Sigel S., Loy H., Wag E. L. Thyrotropin-releasing hormone and shaking behavior in rat. Nature 1975; 253: 739
   PubMed Web of Science ®Google Scholar
• Webster V. A.D., Griffiths E. C., Slater P. Induction of wet-dog shaking in rats by analogues and metabolites of thyrotropin-releasing hormone (TRH). Reg. Peptides 1982; 5: 43
   Google Scholar
• Pranzatelli M. R., Snodgrass S. Enhanced selective 5-HT depletions in the DHT rat model: denervation supersensitivity and recovery of function. Psychopharmacology 1986; 89: 449
   PubMed Web of Science ®Google Scholar
• Pranzatelli M. R., Rubin G., Snodgrass S. R. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding. Brain Research 1986; 364: 57
   PubMed Web of Science ®Google Scholar
• Blurton P. A., Wood M. D. Identification of multiple binding sites for 3H-5-hydroxytryptamine in the rat CNS. J. Neurochem. 1986; 46: 1392
   PubMed Web of Science ®Google Scholar
• Leysen J., Niemegeers J., Van Neuten J., Laduron P. 3H-Ketanserin (R41486), a selective 3H-ligand for serotonin2 receptor binding sites. Molec. Pharmacol. 1982; 21: 301
   PubMed Web of Science ®Google Scholar
• Barbaccia M., Gandolfi O., Chulang D., Costa E. Differences in the regulatory adaptations of the 5-HT2 recognition sites labelled by 3H-mianserin or 3H-ketanserin. Neuropharmacology 1983; 22: 123
   PubMed Web of Science ®Google Scholar
• Nabeshima T., Ishikawa K., Yamaguchi K., Furukawa H., Kameyama T. An ability of phencyclidine as an agonist for serotonin2 (5-HT2) receptors in rat brain. Soc. Neurosci. Abstr. 1986; 12: 362
   Google Scholar
• Mawson C., Whittington H. Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents. Br. J. Pharmac. 1970; 39: 223
   Web of Science ®Google Scholar
• Pranzatelli M. R. In vitro activity of antimyoclonic and anticonvulsant drugs at central serotonin 5-HT-1A, 5-HT-1B, and 5-HT-2 receptors in the rat. Soc. Neurosci. Abstr. 1986; 12: 363
   Google Scholar
• Yarbrough G. G. Studies on the neuropharmacology of thyrotropin-releasing hormone (TRH) and a new TRH analog. Eur. J. Pharmacol. 1978; 48: 19
   PubMed Web of Science ®Google Scholar
• Hichens M. A comparison of thyrotropin-releasing hormone with analogs: influence of disposition upon pharmacology. Drug Metab. Rev. 1983; 14: 77
   PubMed Web of Science ®Google Scholar
• Rastogi R. B., Singhal R. L., Lapierre Y. D. Effects of MK-771, a novel TRH analog, on brain dopaminergic and serotonergic systems. Eur J. Pharmacol. 1981; 73: 307
   Web of Science ®Google Scholar
• O'Donohue T. L., Millington W. R., Handelmann G. E., Contreras P. C., Chronwall B. M. On the 50th anniversary of Dale's law: multiple neurotransmitter neurons. TIPS 1985; 305
   Google Scholar